Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.
Arthritis Rheum. 2006 Aug;54(8):2368-76. doi: 10.1002/art.21978.
Arthritis Rheum. 2006.
PMID: 16868999